MOD3 Pharma joins International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) as an associate member, advancing the future of inhalation science and regulatory excellence.

IPAC-RS is a globally recognized consortium of companies committed to advancing the science, regulation, and quality of OINDPs. Through its strategic workstreams – Global Regulatory Review and Outreach, External Outreach, Product Development, and Delivery Systems – IPAC-RS drives scientific innovation, regulatory engagement, and collaboration across key areas such as CMC, biologics, device design, environmental sustainability, and material quality.

As a new Associate Member, MOD3 Pharma will actively contribute to benchmarking initiatives, collaborative surveys, and the early identification of emerging industry issues, while engaging with global regulators and key stakeholders including PQRI, ISO, USP, EPAG, EP, and EFPIA in a non-product specific context.